Results 1 to 10 of about 49,719 (230)

Optimal Controls of the Highly Active Antiretroviral Therapy [PDF]

Abstract and Applied Analysis, 2020
In this paper, we study generic properties of the optimal, in a certain sense, highly active antiretroviral therapy (or HAART). To address this problem, we consider a control model based on the 3-dimensional Nowak–May within-host HIV dynamics model ...
Ellina V. Grigorieva, Evgenii N. Khailov, Andrei Korobeinikov   +2 more
doaj   +4 more sources

Immunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia [PDF]

Journal of Blood Medicine, 2023
Girma Ashenafi,1 Melatwork Tibebu,2 Dagnamyelew Tilahun,1 Aster Tsegaye2 1Department of Medical Laboratory Sciences, Bule Hora University, Bule Hora, Oromia, Ethiopia; 2Department of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa ...
Ashenafi G, Tibebu M, Tilahun D, Tsegaye A   +3 more
doaj   +2 more sources

Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020 [PDF]

BMC Infectious Diseases, 2023
Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu, Ticheng Xiao, Yuanyi Chen, Houlin Tang, Fangfang Chen, Chang Cai, Qianqian Qin, Decai Zhao, Yichen Jin, Shi Wang, Yushan Hou, Zhen Lu, Luoyao Yang, Hong Liu, Dongqin Xie, Huachun Zou, Fan Lyu   +16 more
doaj   +2 more sources

Highly active antiretroviral therapy [PDF]

BMJ, 2005
Cardiovascular risk needs to be assessed before starting treatment I n the industrialised world the availability of highly active antiretroviral treatment (HAART) for advanced HIV-1 disease has dramatically improved patients' life expectancy.1 However, an unfailing lifelong commitment to antiviral drugs is expected.
Filip, Moerman, Alfons, Van Gompel, Jan, Nimmegeers, Johan, Moerman   +3 more
openaire   +4 more sources

Delftia acidovorans: A Rare Pathogen Isolated from Pleural Fluid in an Immunocompromised Host [PDF]

Journal of Clinical and Diagnostic Research, 2022
Delftia acidovorans is an aerobic, non fermentative gram negative rod that belongs to the Pseudomonas ribosomal Ribonucleic Acid (rRNA) homology Group III. The sources of isolation are sludge, biological waste water treatment plants.
P Ganesh Perumal, B Appalaraju, Preethi Thiruvengadam   +2 more
doaj   +1 more source

Acquired Epidermodysplasia Verruciformis During Highly Active Antiretroviral Therapy.

Indian J Dermatol, 2022
Sil A, Bhanja DB, Panigrahi A, Biswas SK.   +3 more
europepmc   +3 more sources

Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2023
Introduction: Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality in patients infected with Human immunodeficiency virus (HIV).
Mehmet ÇABALAK, Tayibe BAL, Eda Selin POLAT, Sabahattin OCAK, Yusuf ÖNLEN   +4 more
doaj   +1 more source

A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management

Brazilian Journal of Infectious Diseases, 2013
Introduction: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy.
Mansueto Gomes Neto, Ricardo Zwirtes, Carlos Brites   +2 more
doaj   +3 more sources

Poor adherence to highly active antiretroviral therapy and associated factors among people living with HIV in Eastern Ethiopia

SAGE Open Medicine, 2022
Objective: Sustained adherence to highly active antiretroviral therapy is necessary to suppress viral replication and improve immunological and clinical outcomes.
Degu Tegegne, Galana Mamo, Belay Negash, Sisay Habte, Tesfaye Gobena, Shiferaw Letta   +5 more
doaj   +1 more source

Microalbuminuria among HIV-infected patients from a tertiary health facility in northwest Nigeria

International Journal of Medicine and Health Development, 2023
Background: Microalbuminuria and gradual reduction of glomerular filtration rate (GFR) are some of the early manifestations of renal involvement in HIV/AIDS.
Bawa I Abubakar, Kabiru Abdulsalam, Sanni Musa, Isah A Yahaya, Sani Adamu, Daniel O Aina   +5 more
doaj   +1 more source